• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Person › Details

Robert Fischer (Omeicos Therapeutics GmbH)

Fischer, Robert (Omeicos Therapeutics GmbH 201312 Managing Director (CSO))

 

	Organisation	Omeicos Therapeutics GmbH
	Group	Omeicos (Group)
	Product	cardiovascular drug
	Product 2	drug development

Record changed: 2022-04-04

Advertisement

More documents for Robert Fischer

• [1] Omeicos Therapeutics GmbH. (11/2/18). "Press Release: Omeicos Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation". Berlin & Boston, MA....
• [2] Omeicos Therapeutics GmbH. (7/17/18). "Press Release: Omeicos Therapeutics Announces Compelling First-in-Human Data on Lead Compound OMT-28 and Prepares Phase 2 Trial in Atrial Fibrillation". Berlin....
• [3] Omeicos Therapeutics GmbH. (4/27/18). "Press Release: Alexander Gebauer Joins Executive Board of Omeicos Therapeutics and Named CEO and Chairman of Omeicos Ophthalmics". Berlin & Boston, MA....
• [4] Omeicos Therapeutics GmbH. (6/7/17). "Press Release: Omeicos Secures Continued BMBF Support with New €1.7m Research Grant to Advance its Novel Approach to Treat Cardiovascular Diseases". Berlin....
• [5] Omeicos Therapeutics GmbH. (3/1/17). "Press Release: Omeicos Announces First Closing of €8.3 Million Series B Financing Round and the Initiation of Phase 1 Clinical Trial". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.